In this issue of Blood, Hoellenriegel et al provide evidence that NOX-A12, an RNA oligonucleotide able to bind and neutralize CXCL12, effectively interferes with chronic lymphocytic leukemia (CLL) cell chemotaxis and stroma-mediated drug-resistance.1
No takes yet. Share an insight, caveat, or question.
Marasca et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: